smi social media - jan 2013 - gsk facebook pharma case study (gary monk)

30
Pharma Social Media Moving forwards? 24 th January Smi Social Media Conference London Gary Monk Digital Healthcare Consultant @garymonk

Upload: gary-monk

Post on 07-May-2015

1.294 views

Category:

Health & Medicine


1 download

DESCRIPTION

An outline of the GSK FaceBook approach, particularly towards moderation. It outlines the opportunities and challenges of using social media in pharma & healthcare.

TRANSCRIPT

Page 1: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Pharma Social MediaMoving forwards?

24th January Smi Social Media Conference London

Gary MonkDigital Healthcare Consultant

@garymonk

Page 2: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Question?

• Pharma believes Social Media can benefit the industry and its stakeholders

Statement

• Have we made progress towards this statement in the last 2 years?

The audience answered unanimously yes

Page 3: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

All truth passes through 3 stages

First - it is ridiculedSecond – it is violently opposed

Third – it is accepted as being self-evident

Arthur Shopenhauer

I believe we are somewhere between 2 & 3, with variation between companies

Page 4: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

HCP Communities

Corporate Communications

Patient Awareness

Case Discussions

I also planned to also cover HCP communities but due to the level of interest in the GSK case we only covered the corporate comms topic (another subject for another day)

Page 5: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Case 1Corporate Communications (2 way)

Page 6: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK was used as an example of best practice.Disclaimer – I have no professional affiliation to the GSK Facebook page and have not interviewed GSK on this interesting subject. All observations and opinions are my own.

Page 7: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK FaceBook policy is clear and tends to explain why certain things are not acceptable

Page 8: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)
Page 9: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

but please respect the following otherwise our lawyers will be mad at us:

The company reserves the right to remove any postings at its sole discretion (we work with serious medical conditions and we can’t risk unmonitored or unverified medical advice being published).

We know a lot of doctors and trust us - they know about health!

B.I. were highlighted for there excellent use of ‘human’ language to explain their FB policy

Page 10: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK attempted to engage with this persistent detractor, and later adopted the seemingly sensible policy of allowing his posts but not responding

Page 11: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK InitiativesGSK post many of their positive initiatives on their FB page

Page 12: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Sometimes strongly attackedA select few detractors often seize upon these positive posts and attack GSK, in a very strong manner. It is impressive they allow most of these comments to stand

Page 13: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

But have strong popular support

But GSK have a very strong following and receive many positive comments and praise. Often from employees and ex-employees

Page 14: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK successes

Corporate achievements are highlighted

Page 15: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Often attacked by a small ‘hardcore’ group

Again the same individuals will often attack these achievements, and accuse GSK of hypocrisy

Page 16: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Used for HR / Recruitment

GSK use their FB page as a tool for recruitment

Page 17: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

GSK usually respond

And importantly try to respond to enquiries…..

Page 18: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Including ad-hoc questions

….including this ad-hoc product question posted under an HR post on recruitment

Page 19: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

‘Mild’ Criticism

Criticism is not always severe – this example shows a mix of praise and criticism

Page 20: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Employee Feedback/Criticism

Some employees offer mild criticism that many of the corporate events and visits tend to happen at the company head office

Page 21: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Very Strong Criticism related to tragic personal stories

This was a very tragic post, extremely critical of GSK, that caused some debate particularly around a potential adverse event (the product names have been redacted here). The purpose of showing was that despite criticism of GSK, they have been very brave in allowing these type of posts to be shared

Page 22: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Managing Global PR

Global issues were often posted on the GSK FaceBook, where the team would usually respond, in this case pointing the community to an apology on Panadol

Page 23: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Yet with community support?

Interestingly there was criticism of GSK for responding to the critics! And some criticism of the critics.

Page 24: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Leverage Positive StoriesWhat GSK do brilliantly is post regular news items, particularly on positive news items, not directly related to GSK. This helps fill the FaceBook wall with positive commentary and quickly ‘bury’ negative comments further down the news feed. The next 2 slides are examples of this, particularly the London Olympics.

Page 25: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Formula 1

Page 26: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

LondonOlympics

2012

Page 27: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Despite the majority of comments being positive, this post shows you can’t please all of the people all of the time

Page 28: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Some Stats• 2 month snapshot Nov & Dec 2012• 15 Posts• 3059 likes• 122 comments

Positive Comments significantly outweighed Negative Comments. Note this analysis only considered comments that were positive/negative directly to GSK as a company.

Page 29: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

• Need courage & self belief

• Have a strategy to respond to negative comments (or not!)

• Generate positive advocates and news stories

• Have something to say and a purpose

Key Learnings GSK

Page 30: SMi Social Media - Jan 2013 - GSK FaceBook Pharma Case Study (Gary Monk)

Questions or get in touch…..

• twitter => @garymonk• email => [email protected]• linked In => www.linkedin.com/in/garywmonk• phone => +44 7776 242276